James started his career in short oligonucleotide synthesis and point-of-care diagnostic assays following a Ph.D. in DNA Chemistry from the University of Southampton. He then went on to spend the next ten years developing next-generation sequencing technologies, spanning multiple product launches and large-scale sequencing initiatives.